ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases

ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases

J Digit Imaging DOI 10.1007/s10278-016-9938-1 ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases Nikhil Goyal1 & Andrea B. Apolo2 & Eliana D. Berman2 & Mohammad Hadi Bagheri1 & Jason E. Levine3 & John W. Glod4 & Rosandra N. Kaplan4 & Laura B. Machado1 & Les R. Folio1 # Society for Imaging Informatics in Medicine 2017 Abstract Oncologists evaluate therapeutic response in can- compared RECIST v1.1 data from eight patients (16 com- cer trials based on tumor quantification following selected puted tomography exams) enrolled in an IRB-approved ther- Btarget^ lesions over time. At our cancer center, a majority apeutic trial with ENABLE outputs: 10 data fields with a of oncologists use Response Evaluation Criteria in Solid total of 194 data points. All data in ENABLE’s output Tumors (RECIST) v1.1 quantifying tumor progression based matched with the existing data. Seven staff were taught on lesion measurements on imaging. Currently, our oncolo- how to use the interface with a 5-min explanatory instruc- gists handwrite tumor measurements, followed by multiple tional video. All were able to use ENABLE successfully manual data transfers; however, our Picture Archiving without additional guidance. We additionally assessed 42 Communication System (PACS) (Carestream Health, metastatic genitourinary cancer patients with available Rochester, NY) has the ability to export tumor measure- RECIST data within PACS to produce a best response wa- ments, making it possible to manage tumor metadata digi- terfall plot. ENABLE manages tumor measurements and tally. We developed an interface, BExportable Notation and associated metadata exported from PACS, producing forms Bookmark List Engine^ (ENABLE), which produces and data models compatible with cancer databases, obviating prepopulated RECIST v1.1 worksheets and compiles cohort handwriting and the manual re-entry of data. Automation data and data models from PACS measurement data, thus should reduce transcription errors and improve efficiency eliminating handwriting and manual data transcription. We and the auditing process. * Les R. Folio Rosandra N. Kaplan [email protected] [email protected] Nikhil Goyal [email protected] Laura B. Machado [email protected] Andrea B. Apolo [email protected] 1 Radiology and Imaging Sciences, CC, NIH, Building 10, 9000 Eliana D. Berman Rockville Pike, Bethesda, MD 20892, USA [email protected] 2 Genitourinary Malignancies Branch, NCI, NIH, Building 10, 9000 Mohammad Hadi Bagheri Rockville Pike, Bethesda, MD 20892, USA [email protected] 3 Jason E. Levine Center for Cancer Research, NCI, NIH, Building 10, 9000 Rockville [email protected] Pike, Bethesda, MD 20892, USA John W. Glod 4 Pediatric Oncology Branch, CCR, NCI, NIH, Building 10, 9000 [email protected] Rockville Pike, Bethesda, MD 20892, USA J Digit Imaging Keywords Clinical oncology . Data collection . Efficiency . data into Labmatrix, promoting digital management of data Multimedia . PACS . RECIST . Data management . PACS at the source of input and aiming to improve efficiency and metadata minimize transcriptional transfer errors. Current Data Flow Background Following CT or MRI acquisition on cancer patients, radiolo- The most common method of assessing tumor burden in can- gists report findings (the traditional clinical report), often in- cer trials is determining size change of select metastatic le- cluding Bindex^ lesion measurements (not necessarily sions on cross-sectional anatomical imaging such as computed Btarget^ lesions). It is well known that radiologists often do tomography (CT) and magnetic resonance imaging (MRI) not include the necessary quantification of imaging on cancer using the Response Evaluation Criteria in Solid Tumors patients required for tumor assessments on clinical trials [4, 5]. (RECIST) v1.1. RECIST is the criteria used in a majority of When oncologists review tumor images on CT or MRI with- our cancer therapeutic clinical trials at the National Institutes out target lesion measurements, they proceed to measure these of Health Clinical Center (NIH CC) [1] and requires metasta- lesions themselves or request consultations with radiologists tic lesion selection at initiation of treatment with subsequent to ensure objective and verified measurement of target lesions. analysis of lesion size changes over time. This produces enor- Our oncologists perform RECIST calculations manually mous amounts of data that need careful management through- for each patient visit, followed by data entries into multiple out the trial. databases (for example: handwritten RECIST worksheets, the RECIST v1.1 quantifies tumor progression based on linear electronic medical record, research databases, and onsite files measurements in two dimensions (axial images) of selected such as Excel for further analysis). This inefficient flow of patient Btarget^ metastatic lesions (up to five) for each CT or information is outlined in Fig. 2. In addition to being extreme- MRI exam [2, 3]. There can be up to 10 metadata values per ly inefficient, this repeated transcription process is inherently lesion used in RECIST (see Fig. 1 for an example RECIST error-prone and promotes incorrect or discrepant tumor mea- form), with an additional 17 data points per set of select im- surements [6]. ENABLE encourages (rather than Bresists^) ages tracked over time. For example, a clinical trial with 50 radiologists and oncologists to collaborate in patient tumor patients, each of whom has 5 CT exams with three target assessment [5]. lesions per exam, results in over 10,000 data points (see Many oncologists also produce visual analytics such as Appendix 1 for detailed calculation) that must be managed waterfall plots [7, 8]toshoweachpatient’s overall best re- throughout the trial. These are currently handwritten, typed sponse to report on therapeutic efficacy according to RECIST into medical records, and then retyped at least once into a guidelines. This is one of many analytic displays driving the research information database (see Fig. 2), making this pro- need for patient data to be automatically batched into one cess error-prone and extremely inefficient. source with correct RECIST calculations. To address these challenges, we have built a computational strategy through a collaboration with our Picture Archiving Improving the Data Flow Communication System (PACS) vendor for image measure- ments, to be automatically saved for each patient in bookmark Our PACS system allows radiologists and oncologists to co- lists that are exportable files (e.g., as Excel spreadsheets). This register several cross-sectional exams from two or more time allows for digital management from a single source of truth points [9], allowing measurements to be automatically or (SSOT), as opposed to inefficient and error-prone manual data semi-automatically related over time based on their location management. and surrounding anatomy [10]. Moreover, multimedia- We developed an interface we term BExportable Notation enhanced radiology reports with hyperlinked measurements and Bookmark List Engine^ (ENABLE) which extracts veri- [11] and the inclusion of a radiologist assistant (radiology fied data from files that have been directly exported as postdoc, fellow or technologist that verifies baseline date standalone files from PACS and which performs RECIST cal- and relates known target lesions over time) has been shown culations (percent tumor size change), compiles patient cohort to increase measurement consistency among radiologists and data in a single document (with all pertinent calculations), and oncologists [12]. This makes it easier to verify data—apre- auto-populates a summary document (an NCI RECIST requisite to semi-automated data management. worksheet, see Fig. 1a) that is used in our cancer center. Target lesion measurements and associated metadata We also built ENABLE to produce data which is natively are all stored within our PACS in an organized, export- compatible with Labmatrix (BioFortis, Columbia, MD), one able database known as a Bookmark List that is easy to of the research information databases in use in the NIH CC. export and digitally manage in a structured format, ob- This allows direct uploading of patient tumor measurement viating the need for handwriting and duplicating data J Digit Imaging Fig. 1 Blank (left, a) and prepopulated RECIST sheet (right, b). a (left) by ENABLE as one of several output possibilities. These sheets can be Unpopulated (blank) digital RECIST worksheet used at our research cen- saved in Word or a PDF and electronically signed and imported into our ter. b (right) Populated RECIST worksheet semi-automatically generated EMR entry steps from the workflow. Utilizing our PACS ca- data within PACS from September 2015 to February pability to export this tumor data in a consistent format, 2016 (group 2). we developed ENABLE to automate a majority of the data management aspects of the tumor assessment The Bookmark List workflow. Tumor data is stored in our PACS within the Bookmark List in a structured manner, separated into columns based Methods on user configurable categories. For the purpose of auto- mation and to meet our cancer trial needs, we configured Testing Data the view for all radiologists and assistants to a standard- ized bookmark list displaying the following necessary tu- As part of a quality improvement initiative, we retrospec- mor data categories: tively assessed CT scans of the chest, abdomen,

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    12 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us